中國紅包(08316.HK):完成透過根據一般授權認購新股份進行貸款資本化
格隆匯3月4日丨中國紅包(08316.HK)發佈公告,認購協議所載完成的所有先決條件均已達成,已於2025年3月4日落實完成。根據認購協議的條款及條件,公司已向認購人發行及配發合共4531萬股認購股份,認購價爲每股認購股份0.203港元。
認購事項涉及將部分債務資本化爲認購股份,公司使用內部資源就認購事項結算相關費用。由於認購事項產生的所有所得款項按等額基準抵銷債務,故認購事項不會產生所得款項。根據認購協議的條款及條件,公司須於完成後三個月內以現金償付債務的尚未償還結餘。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.